Teva Pharmaceutical Industries (TEVA) Profit Margin History

Historical gross, operating and net quarterly profit margin for Teva Pharmaceutical Industries (TEVA) over the last 10 years. The current net profit margin for Teva Pharmaceutical Industries as of September 20, 2017 is -25.18%.

Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $17.384B $21.903B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.